Stay updated on Cabozantinib Reverses Carfilzomib Resistance in Myeloma Clinical Trial
Sign up to get notified when there's something new on the Cabozantinib Reverses Carfilzomib Resistance in Myeloma Clinical Trial page.
Latest updates to the Cabozantinib Reverses Carfilzomib Resistance in Myeloma Clinical Trial page
- Check3 days agoChange DetectedThe website has updated the 'type of intervention' feature from version v2.13.3 to v2.14.0, indicating a significant change in this functionality.SummaryDifference0.1%
- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check24 days agoNo Change Detected
- Check32 days agoChange DetectedThe website has been updated from version 2.13.2 to 2.13.3.SummaryDifference0.0%
- Check39 days agoChange DetectedThe website has updated the contact details section for the study, now providing information on who to contact for questions about joining the study and where it is taking place, reflecting a revision from v2.12.2 to v2.13.2.SummaryDifference1%
- Check53 days agoChange DetectedThe website has added new features, while several detailed data fields and options for downloading study information have been removed.SummaryDifference2%
- Check61 days agoChange DetectedSeveral key medical and genetic resource links related to multiple myeloma and associated treatments have been removed, which may impact access to important information.SummaryDifference0.4%
- Check68 days agoChange DetectedThe website has been updated to version 2.12.2, with new additions including multiple resources related to multiple myeloma, clinical trials, and medication information, while the previous version 2.12.1 has been removed.SummaryDifference3%
Stay in the know with updates to Cabozantinib Reverses Carfilzomib Resistance in Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cabozantinib Reverses Carfilzomib Resistance in Myeloma Clinical Trial page.